This is the authors' abstract. We don't add key points for this paper.
Probiotics are live microorganism which when administered in adequate amounts confer health benefits to the host. Different probiotic strains are being used in animal feeds. The main goal of current study was to screen the isolate for potential probiotic characteristics viz. different enzyme production, antimicrobial properties, pH/bile salt tolerance, temperature stability, antidiarrheal activity against E. coli and castor oil induced diarrhoea in non-ruminant’s Swiss albino mice and Wistar rats; and acute oral toxicity in mice using OECD guidelines. The results showed that the isolate SKB LAB-19 produces 8 potential enzymes, effective against E. coli and C. perfringensis, tolerant to bile salt and gastric pH, stable at 40-90oC and shows no cytotoxicity. In in vivo studies, SKB LAB19 was found to be safe and displayed promising results to reverse E. coli and castor oil induced diarrhoea in Albino mice and Wistar rats, respectively. An attempt was made to explain mechanism of action and immunomodulatory effects of Bacillus coagulans SKB LAB-19 on reversal of diarrhoeal symptoms, haematological parameters, concentration of immunoglobulins in blood and increases the weight of spleen and thymus. Histopathological pictures showed repair to damaged mucosal epithelium cells and also improves integrity of the goblet cells of colon. Thus, Bacillus coagulans SKB LAB-19 could be an effective probiotic alternative to standard anti-diarrhoeal drugs in humans and animals.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chaudhari et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: